# Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis

> **NCT01408810** · PHASE4 · COMPLETED · sponsor: **Grupo de Estudo da Doença Inflamatória Intestinal** · enrollment: 21 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** Infliximab

## Key facts

- **NCT ID:** NCT01408810
- **Lead sponsor:** Grupo de Estudo da Doença Inflamatória Intestinal
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2012-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01408810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01408810, "Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01408810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*